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ABSTRACT   
 
BACKGROUND: Undiagnosed diabetes mellitus cases are at 
higher risk for diabetic related complications. In low-income 
African countries, patients with undiagnosed diabetes mellitus 
account for 75% of diabetes cases. Psychiatric disorders have a 
greater impact on the global burden of diseases and disability 
associated with chronic diseases like diabetes mellitus and 
cardiovascular diseases. 
METHODS: Institution based cross-sectional study was conducted 
at the University of Gondar Hospital from February to April 2016. 
A total of 205 psychiatric patients aged above 15 years that were 
taking antipsychotic were included by the simple random sampling 
method. Fasting blood glucose, triglycerides and cholesterol level 
were determined from venous blood samples to evaluate diabetes 
mellitus based on WHO criteria.  
RESULTS:  Among 205 psychiatric patients taking antipsychotics, 
15(7.3%) had undiagnosed diabetes mellitus. Duration of 
antipsychotic treatment and sex had a statistically significant 
association with the prevalence of undiagnosed diabetes mellitus. 
As the duration of antipsychotic drug treatment increased by one 
year, the risk of having a diabetes mellitus increase by 1.47 times 
(AOR: 1.47 CI: 1.021-2.125).  
CONCLUSION: The prevalence of undiagnosed diabetes mellitus 
among psychiatry patients taking antipsychotics was higher than 
the estimated diabetes national prevalence of Ethiopia. Screening 
of diabetes mellitus in particular, patients having a longer 
duration of antipsychotic treatment is mandatory to bring more 
undiagnosed cases for medical attention.  
KEYWORDS: Diabetes mellitus, Psychiatric disorder, 
Antipsychotic  
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INTRODUCTION  
 
Diabetes mellitus (DM) is a complex metabolic 
disorder characterized by persistent 
hyperglycemia resulting from defects in insulin 
secretion, insulin action or both. There are four 
types of diabetes mellitus (DM), classified as 
type 1 diabetes mellitus, type 2 diabetes mellitus 
(T2DM), gestational diabetes and other types of 
DM (1). 
In 2013, 382 million people had DM; this 
number is expected to rise to 592 million by 
2035. Most people with the DM live in low and 
middle-income countries (2). Ethiopia ranked 
among the ten top countries in Africa with a 
higher prevalence of DM. According to 
International diabetic federation (IDF) estimated 
national diabetes prevalence was 4.36% in 2013 
(3).   
About 75% of the DM patients are 
estimated to be undiagnosed in low-income 
African countries (4). The undiagnosed DM 
cases, they remain untreated and they are one of 
the reasons for a poor glycemic control level of 
patients. This will cause diabetic complications, 
such as heart, kidney, and eye diseases, lower 
limb amputations and mental disorders (3, 5). 
Psychiatric disorder or mental disorder is a 
clinically significant behavioral or psychological 
syndrome or pattern that occurs in an individual 
and associated with present distress or disability 
(6). In 2010, mental, neurological and substance 
use disorders accounted for 10.4%, 2.3% and, 
28.5% of global disability life years, yet remain 
the lowest on the agenda of policy-makers, 
particularly in developing countries (7, 8). Study 
done in Ethiopia shows, the major psychiatric 
disorders are schizophrenia (56.1%) followed by 
bipolar disorder (20.6%) and major depressive 
disorder (MDD)  (11.4%) (8). 
People with mental illness such as 
schizophrenia, depression or bipolar disorder 
have worse physical health and reduced life 
expectancy compared to the general population. 
This excess mortality is due to the fact that 
people with mental disorder are more likely to 
be overweight, and to have DM, hypertension 
and dyslipidemia (9, 10).  
Despite the increased risk of DM and 
cardiovascular disease (CVD), many patients 
with mental disorder have limited access to 
general health care with less opportunity for 
CVD and DM risk screening and prevention 
than would be expected in non-psychiatric 
population (11, 12).  
DM is highly prevalent in people with 
psychotic disorders, including schizophrenia and 
schizoaffective disorders. The exact prevalence 
is difficult to estimate since DM is often under-
diagnosed in people with psychiatric disorders. 
The association between DM and psychosis is 
complex and multifactorial. Antipsychotic 
medication, poor lifestyle and genetic loading 
increase DM risk (12). 
In addition, chronic stress is a risk factor in 
the incidence of DM and worsens metabolic 
control, which leads to diabetes-related 
complication. Patients with psychiatry disorder 
shows over-activation of both the hypothalamic–
pituitary–adrenal medullary axes. These 
endocrine systems respond to stress by an 
increase in the production of diabetogenic 
hormones cortisol and adrenaline. It is proposed 
that both hormones can raise blood sugar and 
play a part in insulin resistance and the onset of 
DM (13). 
Research findings from different studies 
indicated that the prevalence of DM in 
psychiatric patients was higher than the one in 
the general population. Therefore, this study will 
provide information about the magnitude of 
undiagnosed DM in psychiatry patients taking 
antipsychotics since no sufficient studies have 
been done  in Ethiopia.  
 
METHODS 
 
Study area, study design, and study 
participants:  
An institution based cross-sectional study was 
carried out from February–April 2016 at the 
University of Gondar Hospital Psychiatry Clinic, 
which is found in Gondar Town. All psychiatric 
patients aged above 15 years, receiving 
antipsychotic drugs and voluntary to give 
informed consent were included. 
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Sample size and sampling technique: A total 
of 205 individuals were enrolled in the study. 
Psychiatric patients aged ≥15 years with a 
diagnosis of the major psychiatric problem were 
included. The simple random sampling 
technique was used to recruit study participants, 
who has been following antipsychotic treatment 
during the study period.     
Data collection and laboratory methods: Data 
were collected by pretested and semi-structured 
Amharic version questionnaire using interview 
technique. During the data collection, patients 
who were taking antipsychotic drugs were 
interviewed by the enumerators using the 
questionnaire. 
At every data collection spot, sufficient 
explanation about the aim of the research was 
given to the patients or caretakers of psychiatry 
patients. After informed consent was obtained, 
participants were interviewed face-to-face on the 
first visit, and blood samples were collected if 
they were in the fasting state. However, patients 
in the non-fasting state were instructed to be on 
overnight fasting eights up to ten hours. Then, 
three ml of blood sample was collected in a plain 
tube and centrifuged at 3000 RPM for 10 
minutes, and serum was separated. The samples 
were analyzed within two hours using automated 
clinical chemistry analyzer (A25 BIOSYSTEM). 
In addition to the fasting plasma glucose (FPG), 
the laboratory testing included the levels of total 
blood cholesterol (TCHO) and triglycerides 
(TG). Based on the laboratory FBG result, 
diabetes mellitus was defined as FPG of ≥ 
7.0mmol/l (126mg/dl). 
 
Quality assurance: Pre-test was done to check 
clarity, acceptability and consistency of the 
structured questionnaire. The reliability of the 
laboratory findings was assured by 
implementing quality control measures during 
the whole process of the laboratory works (pre-
analytical, analytical and post-analytical quality 
control steps were followed). All materials, 
equipment and procedures were adequately 
controlled. A control was run to check the 
functionality of clinical chemistry automation, 
which was used for conducting laboratory 
analysis. 
 
Data processing and analysis: All patient data 
were registered in laboratory worksheet during 
the study period. Then, the data were cleaned, 
edited, checked for completeness and were 
entered to EPI info version 3.5.3 and transferred 
to the Statistical Package for Social Sciences 
(SPSS) statistical software version 20 for 
analysis.  
The binary logistic regression model was 
used to examine the factors associated with 
undiagnosed DM among study participants. 
Variables with p< 0.2 in the bivariate analysis 
were considered for multivariate analysis. Then, 
study findings were explained in words and 
tables. Finally, from a multivariate logistic 
regression model, variables with P-value< 0.05 
were taken as statistically significant. 
Ethical approval and consent to participate: 
Ethical clearance was obtained from the Ethical 
Review Board of the School of Biomedical and 
Laboratory Sciences, College of Medicine and 
Health Sciences, University of Gondar. 
Moreover, a letter of support was secured from 
administrators of the University of Gondar 
Hospital. Following an explanation of the 
purpose and the possible risks of the study, 
written consent was obtained from all study 
subjects, which assured that participation was on 
a voluntary basis. Participants with positive 
results for diabetes mellitus were referred for 
treatment to the Diabetic Clinic within the 
Hospital. The collected data were kept 
confidential. 
 
RESULTS 
 
Socio-demographic characteristics of the 
study participants: A total of 205 psychiatric 
patients taking antipsychotics were included in 
the study. Out of all the study participants, 108 
(52.7%) were females. The mean age of the 
study participants was 33.73 ± 11.46 (range: 15 
to 81 years), and the majority (60.5%) of the 
study participants were urban inhabitants 
(Table1). 
 
of antipsychotic drug treatment was 2.62 ± 1.8 
years. The mean duration of antipsychotic 
treatment for patients with an undiagnosed DM 
was Mean ± SD of 4.4 ± 1.53 years. (Table 2). 
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Table 1: Socio-demographic characteristics of psychiatric patients receiving antipsychotic drugs at the 
University of Gondar Hospital, northwest Ethiopia, 2016 (n=205). 
 
 
 
Behavioral characteristics of the study 
participants: The majority of the participants 
were schizophrenia patients, 106 (51.7%), 
followed by MDD, 68 (33.2%), and Bipolar 
disorder, 31 (15.1%). Almost all of the study 
participants, 203 (99%), had no family history of 
DM. Nine out of 15 (60%) DM cases were 
schizophrenia patients,  six out of 15 (40%) 
undiagnosed DM cases were MDD patients and 
there was no case of undiagnosed DM in Bipolar 
patients. The mean duration of antipsychotic drug 
treatment was 2.62 ± 1.8 years. The mean 
duration of antipsychotic treatment for patients 
with  undiagnosed DM was 4.4 ± 1.53 years. 
(Table 2). 
Prevalence of undiagnosed diabetes mellitus: 
According to the ADA criteria, the prevalence of 
undiagnosed DM was 7.3% (CI: 3.74 - 10.86). 
Among participants with undiagnosed DM, the 
prevalence of undiagnosed DM was more 
prevalent in females than males (5.9% vs. 1.5%) 
(P-value=0.028). The prevalence of undiagnosed 
DM increased across four age groups: 0%, 1.5%, 
2.4% and 3.4% among participants aged < 25, 25-
34, 35-45 and above 45 years respectively (Table 
3). 
 
 
 
Variable Number                        % 
Sex 
Male 
Female 
 
97 
108 
 
47.3 
52.7 
Age 
<25 
  25-34 
  35-45 
>45 
 
54 
74 
42 
35 
 
26.3 
36.1           
20.5 
17.1 
Marital Status 
Single 
   Married 
    Separated/divorced 
Widowed 
 
107 
68 
29 
1 
 
52.2  
33.1 
14.1 
0.5 
Educational Status 
Illiterate 
Read and write 
Primary & secondary School  
College and Above 
 
101 
39          
37 
28 
 
49.3 
19.0 
18 
13.7    
Religion  
    Orthodox 
    Muslim 
    Others 
 
171 
30 
4 
 
83.4    
14.6 
2 
Residence 
Rural 
Urban 
 
81 
124 
 
39.5          
60.5 
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Table 2: Prevalence of undiagnosed diabetes mellitus by behavioral characteristics, clinical and 
anthropometric measurements of study participants at University of Gondar Hospital, northwest Ethiopia, 
2016 
 
 
Factors associated with undiagnosed diabetes 
mellitus: In the bivariate analysis of variables 
with undiagnosed diabetes mellitus, sex, duration 
of antipsychotic treatment, total blood cholesterol 
and triglyceride were found to have a statistically 
significant association with the prevalence of 
undiagnosed DM. 
However, in the multivariate logistic 
regression analysis of the study variables, there 
was a statistically significant association only 
with sex and duration of antipsychotic treatment. 
Females were found to have 7.1 times to be at risk 
of having undiagnosed DM than males (AOR: 
7.1, CI: 1.4 - 36.1), and as the duration of 
antipsychotic drug treatment increased by one 
year, the risk of having DM increased by 1.47 
units (AOR: 1.47, CI: 1.021-2.125) (Table 4). 
 
 
 
 
 
Variable Category Total 
 
N (%) 
          UDM 
  Yes               No 
 N (%)        N (%) 
Smoking status  
 
Non smoker   
Current Smoker  
Ex-smoker 
191(93.2) 
12(5.9) 
29(1) 
14(6.8) 
1(0.5) 
0(0) 
177(86.3) 
11(5.4) 
2(1) 
Physical activity 
 
 Light 
Moderate 
Vigorous 
61(29.8) 
105(51.2) 
39(19) 
15(7.3) 
0(0) 
0(0) 
46(22.4) 
105(51.2) 
39(19) 
Blood Pressure 
 
Non hypertensive 
Pre hypertensive 
Hypertensive 
196(95.6) 
7(3.4) 
2(1) 
13(6.3) 
1(0.5) 
1(0.5) 
183(89.3) 
6(2.9) 
1(0.5) 
BMI 
 
Underweight 
Normal 
Overweight 
Obese 
19(9.3) 
137(66.8) 
38(18.5) 
10(4.9) 
1(0.5) 
1(0.5) 
11(5.4) 
2(1) 
18(8.8) 
136(66.7) 
27 (13.2) 
8(3.9) 
Family History of DM                  Yes
No 
2(1) 
203(99) 
0(0) 
15(7.3) 
2(1) 
188(91.7) 
Type of disorder  
 
Schizophrenia 
MDD with Psychotic 
Bipolar with Psychotic 
106(51.7) 
68(33.2) 
31(15.1) 
9(4.4) 
6(2.9) 
0(0) 
97(47.3) 
62(30.2) 
31(15.1) 
Antipsychotic  used 
 
Typical 
Atypical 
Antipsychotic with Antidepressant 
Antipsychotic with mood stabilizer  
92(44.9) 
18(8.8) 
69(33.7) 
26(12.7) 
8(3.9) 
1(0.5) 
6(2.9) 
0(0) 
84(41) 
17(8.3) 
63(30.7) 
26(12.7) 
Blood TCHO Normal 
High 
151(73.7) 
54(26.3) 
7(3.4) 
8(3.9) 
144(70.2) 
46(22.4) 
Blood TG                                            
 
Normal
High 
167(81.5) 
38(18.5) 
9(4.4) 
6(2.9) 
158(77.1) 
32(15.6) 
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Table 3: Prevalence of undiagnosed diabetes mellitus by socio demographic characteristics of study 
participants at University of Gondar Hospital, northwest Ethiopia, 2016. 
 
 
Table 4: Multivariate and bivariate analysis of factors associated with undiagnosed diabetes mellitus 
among psychiatry patients taking antipsychotic drugs at the University of Gondar Hospital, northwest 
Ethiopia, 2016 
Variable 
 
Category Undiagnosed DM COR (95% CI) 
 
AOR (95% CI) P-value 
Yes 
N (%) 
No 
N (%) 
 
Sex 
 
 
Male 
Female 
 
3(1.5) 
12(5.9) 
 
94(45.9) 
96(46.8) 
 
1 
3.91(1.07-14.32)* 
 
 
7.1(1.436-35.4) 
 
 
0.016** 
BMI 
 
Under 
Normal 
Overweight 
Obese 
1(0.5) 
1(0.5) 
11(5.4) 
2(1) 
18(8.8) 
136(66.) 
27(13.2) 
8(3.9) 
1       
0.132(0.008- 2.2) 
7.33(0.87- 61.84) 
4,5(0.355- 57.10) 
 
0.079(0.004-1.49) 
7.1(0.68-74.51) 
2.18(0.133-36.06) 
0.002 
0.091 
0.102 
0.585 
Duration Years of drug use - - 1.44(1.157-1.80)* 1.47(1.021-2.12)** 0.038** 
TCHO 
 
Normal 
High 
7(3.4) 
8(3.9) 
144(70) 
46(22.4) 
1 
3.57(1.23-10.40)* 
 
0.22(0.036-1.408) 
 
0.111 
TG Normal 
 High 
9(3.4) 
6(2.9) 
158(77) 
32(15.6) 
1 
3.29(1.09-9.895)* 
 
1.65(0.403-6.83) 
 
0.485 
NB: *=Significant by bivariate analysis, **=significant by multivariate analysis 
Variable 
 
Category          UDM 
   Yes                No 
 N (%)            N(%) 
Sex 
 
Male 
Female 
3 (1.5) 
12(5.9) 
94(45.9) 
96(46.8) 
Age  
 
<25 
25-34 
35-45 
>45 
0(0.0) 
3(1.5) 
5(2.4) 
7(3.4) 
54(26.3) 
71(34.6) 
36(17.6) 
29(14.1) 
Marital status Married 
Single  
Divorced/separated 
Widowed 
4(2) 
7(3.4) 
4(2) 
0(0) 
64(31.2) 
100(48.8) 
25 (12.2) 
1(0.5) 
Religion 
 
Orthodox 
Muslim  
Others 
12(5.9) 
2(1) 
1(0.5) 
159(77.6) 
28(13.7) 
3(1.5) 
Educational status  
 
Illiterate 
Read and write 
10 and 20 school  
College and above 
11(5.4) 
0(0.0) 
3(1.5) 
1(0.5) 
90(43.9) 
39(19) 
34(16.5) 
27(13.2) 
Residence Rural 
Urban 
4(2) 
11(5.4) 
77(37.6) 
113(55.1) 
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DISCUSSION 
 
In this study, of 205 psychiatric patients, 15 
(7.3%) met the WHO criteria for the DM. The 
prevalence of undiagnosed DM (7.3%) found in 
this study was higher than the estimated DM 
national prevalence of Ethiopia, 4.36% reported 
by the IDF in 2013 (3). This may be associated 
with poor health habits, low access to health care, 
the diabetogenic effect of the antipsychotic drugs 
and the global increase in the trend of the DM 
epidemic in developing countries. 
The prevalence of undiagnosed DM among 
patients with psychiatric disorder in this study,   
(7.3%) (CI: 3.74 - 10.86), was lower than the 
findings of the studies among psychiatric patients 
in Palestine (10.8%) (14), Australia (12.1%) (15) 
and USA (10.2%) (16). It is likely that the 
differences observed in these studies were having 
a higher national prevalence of DM which could 
be due to lifestyle and genetic factors. 
To the contrary, the prevalence (7.3%) of 
undiagnosed DM was also higher than the study 
finding in mental health care organizations in 
Holland, 6.5% (17), University of Rochester 
Medical Center London, 4.9% (18) and in 
Srilanka, 4.75% (19). This could be due to 
deficiency in DM screening and early diagnosis 
because of insufficient resources and practical 
considerations. 
A higher prevalence of undiagnosed DM was 
observed in females (5.9%) than in males (1.5%), 
which is consistent with a study carried out on 
psychiatric patients in China (Male = 18.3% vs. 
Female = 31.3%) (20)and USA (Males = 9.5% vs. 
Females = 14.7%) (21). The possible reason for a 
highly represented undiagnosed DM among 
female psychiatric patients in this study was due 
to poor health seeking behavior and adopting a 
sedentary lifestyle. 
Undiagnosed DM was significantly 
associated with duration of antipsychotic 
treatment in which as the duration of 
antipsychotic drug treatment increased by one 
year, the risk of having undiagnosed DM 
increased by1.47 (AOR: 1.47, CI: 1.021-2.125). 
The finding of this study was also supported by a 
study done in South London, which showed an 
association of duration of antipsychotic treatment 
with an increased risk of DM (OR 1.01) (22). The 
hypothesized diabetogenic effects of longer 
duration of antipsychotic treatment were on 
antipsychotic-induced weight gain. This starts 
with the eventual development of insulin 
resistance and pancreatic beta-cell failure (23).  
Limitation of the study: Due to financial 
constraints, we were unable to incorporate tests 
like oral glucose tolerance test (OGTT). OGTT 
can increase the specificity of the study besides 
only the FPG test was used to evaluate 
undiagnosed DM this could underestimate the 
prevalence of undiagnosed DM. In addition, we 
used cross-sectional study design and this may not 
show exactly the cause and effect relationship 
between variables.  
In conclusion, this study has found a higher 
prevalence of undiagnosed DM among psychiatry 
patients taking antipsychotics than the one in the 
general population of Ethiopia according to IDF 
2014 estimated report. The risk factors associated 
with the prevalence of undiagnosed DM were the 
duration of antipsychotic drug treatment and sex 
of the participants.  
We reccomend early diagnosis and screening 
of DM in psychiatric patients, in particular, those 
patients with advanced age and longer duration of 
antipsychotic treatment. This will have a major 
importance to reduce the risk of DM-related 
complications like cardiovascular diseases by 
adopting lifestyle intervention. 
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